Diabetes Dialogue: December 2022


Although the year may be winding to a close, the diabetes community has still been moving ahead at a breakneck pace. In a year marked by historic advances, including the approval of tirzepatide (Mounjaro) and teplizumab (Tzield), the month of December has played host to the long-awaited US FDA clearance of the Dexcom G7 Continuous Glucose Monitoring System, the American Diabetes Association’s annual update of their Standards of Care in Diabetes, and the Association of Diabetes Care and Education Specialists (ADCES) Diabetes Technology Conference.

To bring the year to a close, the hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives Diana Isaacs, PharmD, an endocrine clinical pharmacist and coordinator of the CGM Program Coordinator at the Cleveland Clinic, and Natalie Bellini, DNP, an endocrine nurse practitioner at R&B Medical Group, sat down to discuss recent developments in the field, with a spotlight on the Dexcom G7 CGM, key takeaways from the ADA’s Standards of Care in Diabetes—2023, and perspective from the ADCES Diabetes Technology Conference 2022.

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is available in an audio-only format on Spotify and Apple Podcasts.

Related Videos
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Jennifer Martin, PhD: Boosting CPAP Adherence in Women with Sleep Apnea
Video 2 -  4 KOLs are featured in, "Educating Primary Care Clinicians on Outpatient HE Management and Ammonia Testing"
Video 1 - 4 KOLs are featured in, "Exploring the Impact of Hepatic Encephalopathy on Patients and Their Families "
© 2024 MJH Life Sciences

All rights reserved.